Responses
Case Reports: Adverse drug reactions and complications
Haemophagocytic lymphohistiocytosis as a complication of combination anti-PD-1 and anti-CTLA-4 checkpoint inhibitor immunotherapy for metastatic melanoma, and the outcome of rechallenge with single-agent anti-PD-1 immunotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.